Sunday Mar 21, 2010
Top Stories: Sandra Bullock Lady Gaga Idol SXSW March Madness
LATEST ON:

Nycomed

PR Newswire: Health / Biotech | 4 days ago

Micromet Closes $80.5 Million Public Offering of Common Stock

...and biotechnology companies, including sanofi-aventis, Bayer Schering Pharma, Merck Serono, MedImmune and Nycomed. Safe Harbor Statement This press release contains forward looking...

JavaScript and Flash are required to fully enjoy Evri

Fort Wayne Journal Gazette | 1 week ago

Swedes turn to venture capital

...for Nordic Capital, a Stockholm-based private-equity firm that has investments in companies from Nycomed, a maker of medical diagnostics, to Thule, the Swedish manufacturer of...

"Everyone is very hesitant about the auto sector because of how it's been hit by the crisis," said Katarina Vestlund, a spokeswoman for Nordic Capital, a Stockholm-based private-equity firm that has investments in companies from Nycomed, a maker of medical diagnostics, to Thule, the Swedish manufacturer of sports racks.

Swedes venture into auto capital Detroit Free Press | 3 weeks ago

PR Newswire: Health / Biotech | 3 weeks ago

DURECT and Nycomed Amend POSIDUR(TM) License Agreement to Separate Funding and Control of U.S. and E.U. Clinical Programs and to Expand Territory

...retains full ownership of POSIDUR in the U.S., Canada, Japan and other territories not granted to Nycomed. "Nycomed has been a strong partner for DURECT since the inception of our...

Seeking Alpha | 1 month ago

Russia: Big Pharma Seeking Out New Markets

...2020. The government is encouraging further construction of manufacturing facilities within Russia. Recently, Nycomed announced plans for building a plant in Russia by 2013 and...

Medical News Today | 1 month ago

DURECT Initiates U.S. Pivotal Phase III POSIDUR(TM) Clinical Trial

...the agreement, DURECT will manufacture and supply the product to Nycomed for commercial sale in the territory licensed to Nycomed. DURECT retains full ownership of POSIDUR in the U.S.,...

Prime Newswire | 2 months ago

Immunomedics Receives First Milestone Payment From Nycomed

...monoclonal antibodies to treat cancer and other serious diseases, today announced the receipt of $5 million from Nycomed, GmbH, for reaching the first clinical milestone event under the...

Indiana Times - The Economic Times | 2 months ago

Cadila: Growth should match valuation

CadilaaEUR™s contract-manufacturing business built through joint ventures with Switzerland-based Nycomed, US-based Hospira and others is also gradually contributing to companyaEUR™s...

New York Daily News | 3 months ago

Actovegin seen as aid for doping

...blood after the red and white blood cells, proteins, platelets and other materials are removed. According to Nycomed, which produces it, Actovegin "contains a number of physiological...

Medical News Today | 3 months ago

DURECT Reports Positive Phase IIb Data From POSIDUR(TM) Clinical Program

...agreement, DURECT will manufacture and supply the product to Nycomed for commercial sale in the territory licensed to Nycomed. DURECT retains full ownership of POSIDUR in the U.S., Canada,...

New York Daily News | 3 months ago

To the bulk of bodybuilders, doping agent seems well-known

...that steroid-friendly world. "Everybody swears by it. Evidently it has some advantage." A spokesperson for Nycomed, the Switzerland-based company that produces Actovegin, said the...

Reuters | 5 months ago

Abbott-Solvay a bitter pill for Nycomed banks

Solvay's 4.5 billion euro ($6.6 billion) drug unit sale to Abbott Laboratories is a bitter pill for rival bidder Nycomed and its banks, including Goldman Sachs and JP Morgan, who have...

Reuters | 5 months ago

DEALTALK-UPDATE 1-Abbott-Solvay a bitter pill for Nycomed banks

...$25-28 million advising Abbott * Citi, Morgan Stanley, Rothschild may split $29-32 million * Five Nycomed banks miss out on up to $75 million of fees For more Reuters DEALTALKS,...